Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Nxera Pharma - Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing
Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing
GlobeNewswire

New company (“NewCo”) co-founded by Nxera with a syndicate of leading healthcare and life sciences-focused investment firms. In return for granting an exclusive worldwide license to the program, Nxera is eligible to receive up to…

smh.com.au - Colin Kruger - $88b bloodbath shows Trump is not the only problem for Aussie pharma giant
$88b bloodbath shows Trump is not the only problem for Aussie pharma giant
The Sydney Morning Herald

There is no longer any pretending that US President Donald Trump and his vaccine sceptic Secretary of Health, Robert F. Kennedy, Jr, are solely to blame for the massive destruction of wealth for investors in Australia's biotechnology champion, CSL.

marketbeat.com - Swedbank AB Takes Position in NewAmsterdam Pharma Company N.V. $NAMS
Swedbank AB Takes Position in NewAmsterdam Pharma Company N.V. $NAMS
MarketBeat

Swedbank AB acquired a new stake in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 90,900…

fool.com - Cory Renauer - GoodRx vs. Hims & Hers Health: Stagnation vs. Growth in Revenue
GoodRx vs. Hims & Hers Health: Stagnation vs. Growth in Revenue
The Motley Fool

GoodRx (GDRX +2.82%) primarily generates revenue by offering a price comparison tool that helps consumers find geographically relevant pricing and access negotiated discounts on prescription drugs across the United States. While expanding its…

thehindu.com - V. Raghavendra - Andhra Pradesh govt.'s move to help local products earn global brand recognition
Andhra Pradesh govt.'s move to help local products earn global brand recognition
The Hindu

As part of its efforts to transform the products made in Andhra Pradesh into recognised global brands, the government has initiated steps to develop Product Perfection Clusters (PPCs) in the Amaravati, Visakhapatnam and Tirupati economic regions…

marketbeat.com - IQVIA Q1 Earnings Call Highlights
IQVIA Q1 Earnings Call Highlights
MarketBeat

Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors IQVIA NYSE: IQV reported record first-quarter revenue and adjusted diluted earnings per share for 2026, with management citing accelerating organic growth across its Commercial…

thehindubusinessline.com - Geopolitical storm batters Dalal Street; Sensex tanks 921 points on Iran war fears, crude surge
Geopolitical storm batters Dalal Street; Sensex tanks 921 points on Iran war fears, crude surge
BusinessLine

Markets opened sharply lower on Monday morning as a fresh flare-up in US-Iran tensions sent crude oil prices surging and rattled investor sentiment, dragging the BSE Sensex down 921 points and the Nifty 50 below the 24,000 mark. The Sensex, which…

marketbeat.com - Vanguard Group Inc. Lowers Position in Catalyst Pharmaceuticals, Inc. $CPRX
Vanguard Group Inc. Lowers Position in Catalyst Pharmaceuticals, Inc. $CPRX
MarketBeat

Vanguard Group Inc. cut its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 3.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,432,247…

marketbeat.com - FY2027 Earnings Estimate for VRTX Issued By Erste Group Bank
FY2027 Earnings Estimate for VRTX Issued By Erste Group Bank
MarketBeat

CRISPR Therapeutics Gains After Earnings as Pipeline Hope Grows Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) - Equities research analysts at Erste Group Bank lowered their FY2027 earnings per share estimates for shares of Vertex…

marketbeat.com - Erste Group Bank Brokers Boost Earnings Estimates for AbbVie
Erste Group Bank Brokers Boost Earnings Estimates for AbbVie
MarketBeat

The Most Important Part of These 3 Big Pharma Earnings Reports Wasn't the Beat AbbVie Inc. (NYSE:ABBV - Free Report) - Erste Group Bank upped their FY2026 earnings per share (EPS) estimates for AbbVie in a research report issued on Tuesday, May…

digiday.com - Tim Peterson - 'Google doesn't care that it's terrible': Brand, agency execs air frustrations with The Trade Desk, Google's Performance Max, Meta's Advantage+
'Google doesn't care that it's terrible': Brand, agency execs air frustrations with The Trade Desk, Google's Performance Max, Meta's Advantage+
Digiday - The home of modern media and marketing

But TTD's transparency troubles are almost quaint in the face of the black boxes that ad buyers are having to deal with in the form of AI-powered ad platforms like Google's Performance Max and Meta's Advantage+. “Google's never been…

kareldonk.com - Think carefully before getting tested for HIV
Think carefully before getting tested for HIV
Karel Donk

Following is an English translation of an article I wrote that was published on Starnieuws yesterday. The original article is in Dutch and you can read it on Starnieuws if you prefer that version. An article on Starnieuws from May 4 describes a…

marketbeat.com - Johnson Controls International Q2 Earnings Call Highlights
Johnson Controls International Q2 Earnings Call Highlights
MarketBeat

3 Industrial Names That Will Benefit from Rising CapEx in 2026 Johnson Controls International NYSE: JCI reported stronger fiscal second-quarter results and raised its full-year earnings outlook, citing sustained demand for applied HVAC systems…

marketbeat.com - The Chemours Company $CC Stock Position Boosted by Vanguard Group Inc.
The Chemours Company $CC Stock Position Boosted by Vanguard Group Inc.
MarketBeat

Vanguard Group Inc. boosted its stake in The Chemours Company (NYSE:CC - Free Report) by 2.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 17,920,868 shares…

marketbeat.com - The Goldman Sachs Group, Inc. $GS Shares Acquired by NewEdge Wealth LLC
The Goldman Sachs Group, Inc. $GS Shares Acquired by NewEdge Wealth LLC
MarketBeat

NewEdge Wealth LLC boosted its holdings in The Goldman Sachs Group, Inc. (NYSE:GS - Free Report) by 74.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned…

Receive a Daily briefing on Pharma Industry News

Get Started